🧬 "Be On It”: High-Stakes Deals & Building World-Class Teams | Sujal Patel (Part 3/4)

In this episode of The Biotech Startups Podcast, we dive into part three of Founder and CEO at Nautilus Biotechnology, Sujal Patel’s story—zooming in on the high-stakes path to Isilon’s acquisition by EMC and what it really feels like to negotiate while your company, your board, and the market clock are all in motion. Sujal walks through how the “strategic partnership” conversations revealed themselves as acquisition positioning, why EMC’s approach felt unusually aggressive and old-school, and how a deal can appear to die on the finish line—only to roar back to life under intense time pressure. Sujal also shares the tactical and emotional reality of price negotiation, from holding the line when an acquirer tries to anchor you, to staying disciplined in your responses, to making decisions fast when the range tightens and leaks force a deadline. From there, the conversation expands into what happens after the announcement: the commitments he made to EMC about scaling the business, the organizational decisions that protected long-term value, and the personal calculus behind eventually leaving—even when bigger roles were on the table.